Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents

Publisher： Karger

E-ISSN： 1423-0232|77|6|358-365

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.6, 2010-01, pp. : 358-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1131-1136

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐term effects of anti‐TNF‐α agents on patients with chronic viral hepatitis C and B infections

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 40-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Long-Term Administration of Bisphosphonates in Elderly Cancer Patients

By  

Oncology, Vol. 67, Iss. 2, 2004-10 ,pp. : 112-116

Karger

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W.   Trenkwalder Peter   Hollanders Geert   Zhao Yanxing   Liao Weichi  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms

By Scarpero Harriette   Sand Peter K.   Kelleher Con J.   Berriman Sandra   Bavendam Tamara   Carlsson Martin  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 921-930

Informa Healthcare

Access to resources Recommend Favorite